Ciloa
PrivateLast Round
Grant
Jul 8, 2025
Total Funding Raised
$13.07M
Company Overview
Ciloa is a biotechnology company that operates an exosome-based bioengineering platform to create functional therapies for metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ciloa Comparables
Compare Ciloa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ILIAS Biologics Inc. | 83% | |
| Vesicle Therapeutics | 83% | |
| Evox Therapeutics | 83% | |
Ciloa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 8, 2025 | ||||
| Grant | Mar 8, 2022 | ||||
| Early Funding | Mar 8, 2022 |
Ciloa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2025
$7.6M grant awarded by Bpifrance
- Mar 8, 2022
$1.64M grant round led by Bpifrance.
Ciloa Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ciloa's valuation, stock price, and market status.